Sequana Medical receives CE Mark Approval for the ALFApump™ System and adds Key Executive to Team
on 13/07/2011 16:34
New technology expands treatment options for patient with refractory ascites due to liver cirrhosis. Dr. Farzana Malik joins as Vice President of Market Access and Reimbursement.
Read more
Read more

